Financial Engines Advisors L.L.C. Verastem, Inc. Transaction History

Financial Engines Advisors L.L.C.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 12, 2021	SELL	$2.54 - $4.07 $254,000 - $407,000	-100,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.69 - $4.2 $169,000 - $420,000	100,000 New	100,000 $172,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Financial Engines Advisors L.L.C., based on Form 13F filings with the SEC.

Stay updated on Financial Engines Advisors L.L.C. with notifications on news.